Gadski RA - Search Results

1

Discovery of a beta-MSH-derived MC-4R selective agonist.

Mayer JP, Hsiung HM, Flora DB, Edwards P, Smith DP, Zhang XY, Gadski RA, Heiman ML, Hertel JL, Emmerson PJ, Husain S, O'brien TP, Kahl SD, Smiley DL, Zhang L, Dimarchi RD, Yan LZ. Mayer JP, et al. Among authors: gadski ra. J Med Chem. 2005 May 5;48(9):3095-8. doi: 10.1021/jm0501432. J Med Chem. 2005. PMID: 15857110

2

Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold.

Yan LZ, Flora D, Edwards P, Smiley DL, Emmerson PJ, Hsiung HM, Gadski R, Hertel J, Heiman ML, Husain S, O'Brien TP, Kahl SD, Zhang L, Dimarchi RD, Mayer JP. Yan LZ, et al. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4611-4. doi: 10.1016/j.bmcl.2005.06.081. Bioorg Med Chem Lett. 2005. PMID: 16105738

3

Structure-activity relationships of beta-MSH derived melanocortin-4 receptor peptide agonists.

Yan LZ, Hsiung HM, Heiman ML, Gadski RA, Emmerson PJ, Hertel J, Flora D, Edwards P, Smiley D, Zhang L, Husain S, Kahl SD, DiMarchi RD, Mayer JP. Yan LZ, et al. Among authors: gadski ra. Curr Top Med Chem. 2007;7(11):1052-67. doi: 10.2174/156802607780906591. Curr Top Med Chem. 2007. PMID: 17584126 Review.

4

Synthesis and SAR of novel histamine H3 receptor antagonists.

Jesudason CD, Beavers LS, Cramer JW, Dill J, Finley DR, Lindsley CW, Stevens FC, Gadski RA, Oldham SW, Pickard RT, Siedem CS, Sindelar DK, Singh A, Watson BM, Hipskind PA. Jesudason CD, et al. Among authors: gadski ra. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3415-8. doi: 10.1016/j.bmcl.2006.04.004. Epub 2006 May 3. Bioorg Med Chem Lett. 2006. PMID: 16677814

5

Central H3R activation by thioperamide does not affect energy balance.

Sindelar DK, Shepperd ML, Pickard RT, Alexander-Chacko J, Dill MJ, Cramer JW, Smith DP, Gadski R. Sindelar DK, et al. Pharmacol Biochem Behav. 2004 Jun;78(2):275-83. doi: 10.1016/j.pbb.2004.03.019. Pharmacol Biochem Behav. 2004. PMID: 15219768

6

Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.

Gehlert DR, Schober DA, Beavers L, Gadski R, Hoffman JA, Smiley DL, Chance RE, Lundell I, Larhammar D. Gehlert DR, et al. Mol Pharmacol. 1996 Jul;50(1):112-8. Mol Pharmacol. 1996. PMID: 8700103

7

The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors.

Gehlert DR, Gackenheimer SL, Schober DA, Beavers L, Gadski R, Burnett JP, Mayne N, Lundell I, Larhammar D. Gehlert DR, et al. Eur J Pharmacol. 1996 Dec 30;318(2-3):485-90. doi: 10.1016/s0014-2999(96)00797-2. Eur J Pharmacol. 1996. PMID: 9016942

8

Synthesis of 4 alpha-(2-propenyl)-5,6-secocholestan-3 alpha-ol, a novel B-ring seco analog of the hypocholesterolemic agent 4 alpha-(2-propenyl)-5 alpha-cholestan-3 alpha-ol.

Lin HS, Rampersaud AA, Richett ME, Beavers LS, McClure DB, Gadski RA. Lin HS, et al. Among authors: gadski ra. Steroids. 1998 Apr;63(4):202-7. doi: 10.1016/s0039-128x(98)00004-x. Steroids. 1998. PMID: 9589554

9

Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites.

Statnick MA, Schober DA, Gackenheimer S, Johnson D, Beavers L, Mayne NG, Burnett JP, Gadski R, Gehlert DR. Statnick MA, et al. Brain Res. 1998 Nov 9;810(1-2):16-26. doi: 10.1016/s0006-8993(98)00855-5. Brain Res. 1998. PMID: 9813224

10

Cloning and characterization of Rhesus monkey neuropeptide Y receptor subtypes.

Gehlert DR, Yang P, George C, Wang Y, Schober D, Gackenheimer S, Johnson D, Beavers LS, Gadski RA, Baez M. Gehlert DR, et al. Among authors: gadski ra. Peptides. 2001 Mar;22(3):343-50. doi: 10.1016/s0196-9781(01)00336-9. Peptides. 2001. PMID: 11287088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page